Peeling Back The Layers: Exploring Apellis Pharmaceuticals Through Analyst Insights
Peeling Back The Layers: Exploring Apellis Pharmaceuticals Through Analyst Insights
剥离层层: 通过分析师的洞察，探索Apellis Pharmaceuticals
The analysis of...Across the recent three months, 12 analysts have shared their insights on Apellis Pharmaceuticals (NASDAQ:APLS), expressing a variety of opinions spanning from bullish to bearish.
在最近的三个月里，12位分析师分享了他们对Apellis制药公司（NASDAQ:APLS）的见解，表达了从看好到看淡的各种观点。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他们最近评级的精简视图，显示了过去30天的不同情绪，并将其与前几个月进行比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $76.17, a high estimate of $100.00, and a low estimate of $46.00. A 6.77% drop is evident in the current average compared to the previous average price target of $81.70.
经由分析师评估的12个月价格目标，提供了一个平均目标为76.17美元，高估为100.00美元，低估为46.00美元的见解。当前平均价格目标比先前的81.70美元的目标价格下降了6.77%。
Exploring Analyst Ratings: An In-Depth Overview
分析师评级:深入了解
The analysis of...
对近期...
登录免费看全文
登录/注册
资讯热榜
更新时间